She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

But 5 to 10 percent of patients, like Mathur, develop the motor symptoms that are a hallmark of Parkinson’s decades earlier. People with early-onset Parkinson’s disease — defined as an age ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in ...

Despite earlier hopes, a rigorous 96-week trial with 194 participants found no improvement in symptoms or slowed disease progression ... treatment for early-stage Parkinson’s.

Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease ...